When the topic of national pharmacare made a resurgence in 2018, the Canadian Breast Cancer Network (CBCN) continued advocacy for an equitable and comprehensive approach to national prescription drug coverage. We have advocated that a national plan should provide Canadians with better access to life-saving medications than they currently have and improve equity of access nationally, so the newly announced legislation for a universal, single-payer, phased approach is a welcomed first step.

June 21, 2023 is National Indigenous Peoples Day. This is a day for all Canadians to recognize and celebrate the unique heritage, diverse cultures and contributions of First Nations, Inuit, and Métis peoples. This is also a day that should call to attention the various issues that Indigenous peoples continue to face, including racism, colonialism, and disparate health outcomes from much of the rest of Canada. Broad determinates of health like geography, accessibility and availability of services, and cultural differences contribute to the challenges faced by Indigenous peoples.

On August 15^th, 2021, Prime Minister Justin Trudeau, leader of the Liberal Party called for a federal election. While there are a many of items and issues to look out for from each parties’ platform, we have dedicated this post to the key takeaways from each party regarding health, healthcare, employment insurance  etc. Although this is not an exhaustive list on all the points raised by the parties regarding health and healthcare, we wanted to provide you with a starting point of navigating the 2021 elections as it relates to breast cancer patients.

Did you know that accessing treatments for stage IV metastatic breast cancer (mBC) is not universal across Canada? We live in a country that promotes universal health care to all but accessing cancer treatment varies by each province.

On June 12^th, the Advisory Council on the Implementation of National Pharmacare released their final report looking at the implementation of a national program to address the inequities that Canadians currently face when it comes to drug access. It outlines 60 recommendations, steps to implementation and key details on things like co-pay, budget costs, strategy for rare diseases, and impacts on patients and providers. Below, we’ve summarized these key details for you to better understand how this new plan for pharmacare would impact you and your family. 

Wendie Hayes of Stoney Creek Mountain, Ontario was diagnosed in 2011 with triple negative metaplastic phyllodes breast cancer at the age of 55 after she discovered a lump in her left breast.  Her cancer is a rare type, affecting less than one percent of breast cancer patients, so it took some time to get the right diagnosis. 

How valuable is patient input to decision-makers and how can we work to make sure that the patient voice is really being heard? These are just some of the important questions that I and many others gathered to discuss at the annual Breast Cancer Patient Group Forum in Vienna, Austria.